Cargando…

Ovarian cancer immunotherapy: opportunities, progresses and challenges

Due to the low survival rates from invasive ovarian cancer, new effective treatment modalities are urgently needed. Compelling evidence indicates that the immune response against ovarian cancer may play an important role in controlling this disease. We herein summarize multiple immune-based strategi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bei, Nash, John, Runowicz, Carolyn, Swede, Helen, Stevens, Richard, Li, Zihai
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831814/ https://www.ncbi.nlm.nih.gov/pubmed/20146807 http://dx.doi.org/10.1186/1756-8722-3-7

Ejemplares similares

Pediatric Cancer Immunotherapy: Opportunities and Challenges
por: Wedekind, Mary Frances, et al.
Publicado: (2018)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
por: Young, Kate, et al.
Publicado: (2018)

Surface-Enhanced Raman Spectroscopy for Cancer Immunotherapy Applications: Opportunities, Challenges, and Current Progress in Nanomaterial Strategies
por: Dey, Shuvashis, et al.
Publicado: (2020)

Nanotechnology in cancer diagnosis: progress, challenges and opportunities
por: Zhang, Ye, et al.
Publicado: (2019)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Challenges and Opportunities for Effective Cancer Immunotherapies
por: Slaney, Clare Y., et al.
Publicado: (2020)

Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer Cells
por: Guduru, Rakesh, et al.
Publicado: (2013)

Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
por: Li, Zihai, et al.
Publicado: (2018)

Cancer immunotherapy: are we there yet?
por: Li, Zihai, et al.
Publicado: (2013)

Targeting inflammasome/IL-1 pathways for cancer immunotherapy
por: Guo, Beichu, et al.
Publicado: (2016)

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
por: Pardee, Angela D., et al.
Publicado: (2012)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities
por: Ren, Anqi, et al.
Publicado: (2023)

Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities
por: Curley, Colleen T., et al.
Publicado: (2017)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
por: Noman, Muhammad Zaeem, et al.
Publicado: (2019)

Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
por: Shi, Guilian, et al.
Publicado: (2019)

The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
por: Salamini-Montemurri, Martín, et al.
Publicado: (2020)

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges
por: Pappas, Evan G., et al.
Publicado: (2023)

Golden Age of Immunotherapy: Challenges and Opportunities
por: Chung, Yeonseok, et al.
Publicado: (2022)

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
por: Cheng, Huiyan, et al.
Publicado: (2020)

Association Between Race/Ethnicity and Survival in Women With Advanced Ovarian Cancer
por: Cheng, Justin J, et al.
Publicado: (2021)

Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
por: Bukhari, Sarah I., et al.
Publicado: (2021)

Immunotherapy for sarcomas: new frontiers and unveiled opportunities
por: Birdi, Harsimrat Kaur, et al.
Publicado: (2021)

Immunotherapy in Ovarian Cancer
por: Siminiak, Natalia, et al.
Publicado: (2022)

New opportunities for nanoparticles in cancer immunotherapy
por: Park, Wooram, et al.
Publicado: (2018)

Opportunities and Challenges of Kava in Lung Cancer Prevention
por: Freeman, Breanne, et al.
Publicado: (2023)

Combination strategies to maximize the benefits of cancer immunotherapy
por: Zhu, Shaoming, et al.
Publicado: (2021)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
por: Mediratta, Karan, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
por: Ocáriz-Díez, Maitane, et al.
Publicado: (2020)

Genetic Improvement of Wheat for Drought Tolerance: Progress, Challenges and Opportunities
por: Bapela, Theresa, et al.
Publicado: (2022)

Ovarian Cancer Immunotherapy and Personalized Medicine
por: Morand, Susan, et al.
Publicado: (2021)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Oncolytic viruses as immunotherapy: progress and remaining challenges
por: Aurelian, Laure
Publicado: (2016)

Exploring the landscape of Babesia bovis vaccines: progress, challenges, and opportunities
por: Santos, John Harvey M., et al.
Publicado: (2023)

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy
por: Gilmore, Elaine, et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
por: Verheye, Emma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p57htm3m6qlg3f4btrlfuos489